Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jan Tack, Jean-Jacques Wyndaele, Greg Ligozio & Mathias Egermark. (2012) A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials. Drug, Healthcare and Patient Safety 4, pages 127-139.
Read now
Read now
Norman Zinner, Les Noe, Lawrence Rasouliyan, Thomas Marshall & Raafat Seifeldin. (2008) Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Current Medical Research and Opinion 24:6, pages 1583-1591.
Read now
Read now
Articles from other publishers (12)
Turgut Topol, Catherine Schuler, Robert E. Leggett, Tasmina Hydery, Sandra Benyamin & Robert M. Levin. (2011) Effect of solifenacin plus and minus antioxidant supplements on the response to experimental outlet obstruction and overactive bladder dysfunction in rabbits—Part 2. Urological Science 22:4, pages 141-146.
Crossref
Crossref
Turgut Topol, Catherine Schuler, Robert E. Leggett, Tasmina Hydery, Sandra Benyamin & Robert M. Levin. (2011) Effect of solifenacin with and without antioxidant supplements on the response to experimental outlet obstruction and overactive bladder dysfunction in rabbits: Part 1. Urological Science 22:3, pages 110-115.
Crossref
Crossref
Martin C. Michel, Matthias Oelke, Monika Vogel & Jean J.M.C.H. de la Rosette. (2011) Which single‐item measures of overactive bladder symptom treatment correlate best with patient satisfaction?. Neurourology and Urodynamics 30:4, pages 510-514.
Crossref
Crossref
Yih-Chou Chen, Chia-Yen Chen & Hann-Chorng Kuo. (2010) Efficacy and Adverse Effects of Solifenacin in the Treatment of Lower Urinary Tract Symptoms in Patients With Overactive Bladder. Urological Science 21:1, pages 38-43.
Crossref
Crossref
Diane Newman, William S Aronstein, Yodit Seifu, Andrea Larson-Peters & Lidia Mongay. (2010) Managing Patients With ‘Wet’ Overactive Bladder: Results of Pooled Studies Show Efficacy of Darifenacin as Measured by ‘Dry Days’. UroToday International Journal 03:06.
Crossref
Crossref
Lambertus P.W. WITTE, Ursula PESCHERS, Monika VOGEL, Jean J.M.C.H. de la ROSETTE & Martin C. MICHEL. (2009) Does the Number of Previous Vaginal Deliveries Affect Overactive Bladder Symptoms and their Response to Treatment?. LUTS: Lower Urinary Tract Symptoms 1:2, pages 82-87.
Crossref
Crossref
Norman Zinner, Les Noe, Lawrence Rasouliyan, Thomas Marshall, M. Christopher Runken & Raafat Seifeldin. (2009) Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: An exploratory subgroup analysis. The American Journal of Geriatric Pharmacotherapy 7:6, pages 373-382.
Crossref
Crossref
William D. Steers & Jeremy B. Tuttle. (2009) Role of ion channels in bladder function and voiding disorders. Current Bladder Dysfunction Reports 4:3, pages 125-131.
Crossref
Crossref
Roger Dmochowski, Andrea Larson-Peters, William Aronstein & Yodit Seifu. (2009) Efficacy of Darifenacin in Patients with Varying Baseline Symptom Severity. UroToday International Journal 02:03.
Crossref
Crossref
Martin C. Michel & Sergio Parra. (2008) Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 378:2, pages 217-224.
Crossref
Crossref
Naveen Pemmaraju & Leonard S. Feldman. (2008) Solifenacin‐induced small bowel pseudo‐obstruction. Journal of Hospital Medicine 3:2, pages 176-178.
Crossref
Crossref
Henry A. Vaccaro, Zhiqiang Zhao, John W. Clader, Lixin Song, Giuseppe Terracina, Lili Zhang & Dmitri A. Pissarnitski. (2008) Solution-Phase Parallel Synthesis of Carbamates as γ-Secretase Inhibitors. Journal of Combinatorial Chemistry 10:1, pages 56-62.
Crossref
Crossref